SBFM Sunshine Biopharma Inc.
Nasdaq · SEC CIK 1402328 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 7 since 2022-02-22, latest 2026-08-11 16:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| NATAN DAVID | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 16:23 | 2026-08-07 | SBFM | NATAN DAVID | Dir | A - Grant | $0.00 | +58.3K | 68.3K | +583% | $0 | |
| 2026-04-14 16:26 | 2026-04-14 | SBFM | NATAN DAVID | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 | |
| 2024-03-05 | 2024-03-04 | SBFM | Slilaty Steve N. | CEO, Dir, 10% | P - Purchase | $0.1 | +100.0K | 130.0K | +333% | +$10.0K | |
| 2024-02-12 | 2024-02-08 | SBFM | Slilaty Steve N. | CEO, Dir, 10% | P - Purchase | $0.1 | +20.0K | 30.0K | +200% | +$2,000 | |
| 2022-12-02 | 2022-11-30 | SBFM | Sebaaly Camille | CFO, Sec | P - Purchase | $0.76 | +30.0K | 174.5K | +21% | +$22.8K | |
| 2022-06-06 | 2022-06-03 | SBFM | Sebaaly Camille | CFO, Sec | P - Purchase | $1.22 | +25.0K | 144.5K | +21% | +$30.5K | |
| 2022-02-22 | 2022-02-18 | SBFM | Slilaty Steve N. | CEO, Dir | D - Sale to Iss | $0.1 | -990.0K | 10.0K | -99% | -$99.0K |
Purchase Sale Sale after option exercise All abbreviations